• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Pharmaceutical Market
    Pharmaceutical News
    Pharmaceutical Stocks
    • Pharmaceutical Market
    • Pharmaceutical News
    • Pharmaceutical Stocks

    Solarvest BioEnergy: Producing The World’s Only Plant-based Organic Certified Omega -3

    Diana Fernandez
    Aug. 30, 2021 07:02AM PST
    Pharmaceutical Investing
    briacell

    Solarvest BioEnergy (TSXV:SVS) has launched its campaign on the Investing News Network.

    Solarvest BioEnergy (TSXV:SVS) plans to deliver solutions in human and animal nutrition, prescription and non-prescription medication and derivatives through its proprietary clean energy algal production platform. 

    Eversea is Solarvest BioEnergy’s consumer brand of products. Eversea has brought the company’s Organic Omega-3 supplement to market through its e-commerce platform on its website. The product features a unique and patented Nanuq Organic Omega-3 ingredient which is certified organic in the European Union and by the USDA.

    Solarvest BioEnergy’s Company Highlights

    • Solarvest BioEnergy is an innovative Canadian technology development company focused on producing a wide range of patented algae-derived products for human and animal nutrition, prescription and non-prescription medication and derivatives. 
    • Solarvest BioEnergy’s key consumer brand is called Eversea which brings the company’s first commercialized Organic Omega-3 product to market. The product is the first and only FDA-approved DHA/EPA Organic Omega-3 supplement that is certified organic, vegan, non-toxic, highly bioavailable, sustainable and non-GMO.  It will be sold through strategic partnerships and white label selling.
    • The company’s proprietary clean microalgae process allows for expedited product development and versatility to produce multiple complex products. 
    • Solarvest BioEnergy’s production technology successfully produced highly valuable and safe bone morphogenetic protein (BMP). 
    • The company has a strong market growth strategy. The company plans to expand its product human therapeutic CBD and THC products.
    • Solarvest BioEnergy is led by a highly experienced management team with expertise and a proven track record of achievements in developing commercial biotech products
    SVS:CA
    tsxv:svs
    The Conversation (0)

    Go Deeper

    AI Powered

    BetterLife's Wholly-Owned Subsidiary, Altum Pharmaceuticals, Obtains Non-Dilutive Financing Commitment From Strategic Investor!

    DGTL Holdings Inc. Signs NYSE Listed CPG Brand as New Key Account

    DGTL Holdings Inc. Signs NYSE Listed CPG Brand as New Key Account

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×